webinar register page

Webinar banner
Small Business Funding Opportunities from the National Cancer Institute
The National Cancer Institute Small Business Innovation Research (NCI SBIR) Development Center provides funding, networking, and mentoring assistance to small businesses with early-stage innovative cancer technology projects. NCI SBIR Program Director, Dr. Xing-Jian Lou, and Program Manager, Dr. Reema Railkar, will present funding opportunities and commercialization resources for entrepreneurs and small businesses. This presentation is appropriate for both established and emerging entrepreneurs in small businesses or academia interested in moving life science technologies to patients and/or marketplace.

Registration closes Friday, July 23rd.

NCI SBIR staff are available to meet with select researchers to discuss potential projects one-on-one following the event. Interested parties should submit specific aims and an executive summary by July 21st. Send email submissions to Ashley Francis at Afrancis@tmc.edu.

TMC ACT is the only cancer therapeutics accelerator building relationships with health care professionals leading the world’s best cancer treatment programs at the Texas Medical Center member hospitals. ACT is a Cancer Prevention and Research Institute of Texas (CPRIT) funded accelerator launched by the Texas Medical Center (TMC) in collaboration with the Gulf Coast Consortium (GCC) and the University of Texas Medical Branch (UTMB) to support Texas-based biotech entrepreneurs and researchers contemplating translations. Learn more about TMC ACT at https://www.tmc.edu/innovation/innovation-programs/tmc-act/.

Jul 29, 2021 10:00 AM in Central Time (US and Canada)

Webinar logo
* Required information


Xing-Jian Lou, PhD
Program Director @Small Business Innovation Research (SBIR) Development Center, National Cancer Institute (NCI)
Dr. Lou is a Program Director in the Small Business Innovation Research Development Center at the National Cancer Institute. She manages SBIR & STTR awards, as well as actively engages in developing targeted solicitations, guiding small businesses to develop applications and facilitating interaction between awardees and potential investors and partners. Dr. Lou has over 15 years’ experience in research and product development for diagnosis and drug development. Prior to joining NCI she held a variety of scientific and management positions in pharmaceutical and biotech companies, including Johnson & Johnson, LumiCyte, Applied Biosystems (now part of Thermo Fisher Scientific corporation) and diaDexus. Dr. Lou received her PhD degree in Molecular & Cellular Pharmacology from University of Miami and completed her postdoctoral training at Stanford University.
Reema Railkar, PhD
Program Manager @Small Business Innovation Research (SBIR) Development Center, National Cancer Institute (NCI)
Dr. Reema Railkar is a Program Manager in the NCI SBIR Development Center. She is a cancer biologist with over 15 years of experience in biochemical, biophysical, and bioanalytical platform solutions and has extensive experience in preclinical studies/application of antibodies and small molecules for anti-cancer therapies. Dr. Railkar has published 10+ scientific articles in international journals; 180+ citations; and h-index - 9.